Google
Trusted Resources: News & Events
Latest announcements and gatherings
Sickle Cell Management During the Blood Crisis With Edward Ivy, MD, MPH
In January, The American Red Cross reported that it was facing “its worst blood shortage in over a decade” amid surging cases of the Omicron COVID-19 virus. For the first time since its inception, the Red Cross declared a “Blood Crisis”, with blood and platelet donations reaching critically low levels.
Among the patients in dire need of blood transfusions such as accident victims and cancer patients are patients with sickle cell disease. Approximately 100,000 cases of sickle cell disease have been recorded in United States, and the current blood shortage could prove dangerous to those affected.
Edward Ivy, MD, MPH, Vice Chief Medical Officer of the Sickle Cell Association of America (SCDAA), spoke of the implications of the blood shortage for patients with sickle cell disease in a wide-ranging interview with HCPLive.
+myBinderRelated Content
-
Sam Rodgers-Melnick, MT-BCSamuel Rodgers-Melnick, MT-BC is a music...
-
Jennifer A. Rothman, M.D.Dr. Rothman treats children with cancer ...
-
What is a Bone Marrow Transplant?https://www.youtube.com/watch?v=wrfT5wqH...
-
Living With Sickle Cell Disease – NHS UKThere are a number of things you can do,...
-
Robust Clinical and Laboratory Response to Hydroxyurea Using Pharmacokinetically Guided Dosing for Young Children Wi...Hydroxyurea is FDA-approved and now incr...
-
California Institute For Regenerative Medicine Awards City Of Hope $5.74 Million For Severe Sickle Cell Disease Clin...The California Institute for Regenerativ...
-
Global Blood Therapeutics Receives EMA PRIME Designation for GBT440 for the Treatment of Sickle Cell Disease (SCD)GBT440 is First Potential Treatment for ...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.